Alanine Aminotransferase (ALT)

Alanine Aminotransferase (ALT)

Test Overview

An alanine aminotransferase (ALT) test measures the amount of this enzyme in the blood. ALT is found mainly in the liver, but also in smaller amounts in the kidneys, heart, muscles, and pancreas. ALT was formerly called serum glutamic pyruvic transaminase (SGPT).

ALT is measured to see if the liver is damaged or diseased. Low levels of ALT are normally found in the blood. But when the liver is damaged or diseased, it releases ALT into the bloodstream, which makes ALT levels go up. Most increases in ALT levels are caused by liver damage.

The ALT test is often done along with other tests that check for liver damage, including aspartate aminotransferase (AST), alkaline phosphatase, lactate dehydrogenase (LDH), and bilirubin. Both ALT and AST levels are reliable tests for liver damage.

Why It Is Done

The alanine aminotransferase (ALT) test is done to:

  • Identify liver disease, especially cirrhosis and hepatitis caused by alcohol, drugs, or viruses.
  • Help check for liver damage.
  • Find out whether jaundice was caused by a blood disorder or liver disease.
  • Keep track of the effects of cholesterol-lowering medicines and other medicines that can damage the liver.

How To Prepare

Avoid strenuous exercise just before having an ALT test.

Tell your doctor if you:

  • Are taking any medicines. Many medicines can interfere with test results. Your doctor may instruct you to stop taking certain medicines for several days before having an ALT test. Some herbs and natural products (such as echinacea and valerian) also can affect ALT results.
  • Are allergic to any medicines.
  • Are or might be pregnant.

Talk to your doctor about any concerns you have regarding the need for the test, its risks, how it will be done, or what the results may mean. To help you understand the importance of this test, fill out the medical test information form(What is a PDF document?).

How It Is Done

The health professional taking a sample of your blood will:

  • Wrap an elastic band around your upper arm to stop the flow of blood. This makes the veins below the band larger so it is easier to put a needle into the vein.
  • Clean the needle site with alcohol.
  • Put the needle into the vein. More than one needle stick may be needed.
  • Attach a tube to the needle to fill it with blood.
  • Remove the band from your arm when enough blood is collected.
  • Put a gauze pad or cotton ball over the needle site as the needle is removed.
  • Put pressure on the site and then put on a bandage.

How It Feels

The blood sample is taken from a vein in your arm. An elastic band is wrapped around your upper arm. It may feel tight. You may feel nothing at all from the needle, or you may feel a quick sting or pinch.

Risks

There is very little chance of a problem from having blood sample taken from a vein.

  • You may get a small bruise at the site. You can lower the chance of bruising by keeping pressure on the site for several minutes.
  • In rare cases, the vein may become swollen after the blood sample is taken. This problem is called phlebitis. A warm compress can be used several times a day to treat this.
  • Ongoing bleeding can be a problem for people with bleeding disorders. Aspirin, warfarin (Coumadin), and other blood-thinning medicines can make bleeding more likely. If you have bleeding or clotting problems, or if you take blood-thinning medicines, tell your doctor before your blood sample is taken.

Results

An alanine aminotransferase (ALT) test measures the amount of this enzyme in the blood. Results are usually available within 12 hours.

Normal

The normal values listed here—called a reference range—are just a guide. These ranges vary from lab to lab, and your lab may have a different range for what’s normal. Your lab report should contain the range your lab uses. Also, your doctor will evaluate your results based on your health and other factors. This means that a value that falls outside the normal values listed here may still be normal for you or your lab.

Alanine aminotransferase

Males:

10–40 units per liter (U/L) or 0.17–0.68 microkats per liter (mckat/L)

Females:

7–35 U/L or 0.12–0.60 mckat/L

High values

Very high levels of ALT may be caused by:

Mildly or moderately high ALT levels may be caused by:

  • Mononucleosis .
  • Hepatitis.
  • Alcohol abuse .
  • An overdose of acetaminophen (Tylenol). People who drink alcohol and take a lot of acetaminophen (such as Tylenol) can also have high ALT blood levels.
  • Growth spurts, especially in young children. Rapid growth can cause mildly elevated levels of ALT.

Slightly high ALT levels may be caused by:

What Affects the Test

Reasons you may not be able to have the test or why the results may not be helpful include:

  • Taking medicines. Talk with your doctor about all the prescription and nonprescription medicines you are taking. You may be instructed to stop taking your medicines for several days before the test.
  • Taking some herbs and natural products, such as echinacea and valerian.
  • Strenuous exercise, injury to a muscle, or injections into a muscle.
  • Recent cardiac catheterization or surgery.

What To Think About

  • The alanine aminotransferase (ALT) value is often used along with the results of the aspartate aminotransferase (AST) test to obtain the AST to ALT ratio. This value can often help determine whether there is damage to the liver related to alcohol abuse. For more information, see the medical test Aspartate Aminotransferase (AST).
  • In children with acute lymphocytic leukemia (ALL), very high ALT levels may mean that the disease is likely to progress rapidly.
  • Many different conditions can raise ALT blood levels, so other testing is usually needed to interpret an abnormal ALT result.

References

Other Works Consulted

  • Chernecky CC, Berger BJ (2008). Laboratory Tests and Diagnostic Procedures, 5th ed. St. Louis: Saunders.
  • Fischbach FT, Dunning MB III, eds. (2009). Manual of Laboratory and Diagnostic Tests, 8th ed. Philadelphia: Lippincott Williams and Wilkins.
  • Handbook of Diagnostic Tests (2003). 3rd ed. Philadelphia: Lippincott Williams and Wilkins.
  • Pagana KD, Pagana TJ (2010). Mosby’s Manual of Diagnostic and Laboratory Tests, 4th ed. St. Louis: Mosby.

Credits

By Healthwise Staff
Primary Medical Reviewer Kathleen Romito, MD - Family Medicine
Specialist Medical Reviewer Peter J. Kahrilas, MD - Gastroenterology
Last Revised February 17, 2010

Last Revised: February 17, 2010

Author: Healthwise Staff

Medical Review: Kathleen Romito, MD - Family Medicine & Peter J. Kahrilas, MD - Gastroenterology

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2011 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Latest Hepatitis B News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

U.S. hepatitis A vaccine rates vary widely

January 25, 2012 — NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).

Most toddler vaccines not linked to blood disease

January 10, 2012 — NEW YORK (Reuters Health) - Although the MMR vaccine has been linked to a heightened risk of a rare blood disorder, other childhood vaccines do not appear to be, researchers reported Monday.

New DNA reader to bring genetics to clinics

January 10, 2012 — NEW YORK (Reuters) - A new DNA reader could bring genetics to medical clinics.

Select news items provided by Reuters Health